Status:
UNKNOWN
Study on Therapy of Non-invasive Prolactinoma
Lead Sponsor:
First Affiliated Hospital, Sun Yat-Sen University
Conditions:
Prolactinoma
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
the study aim to investigate the endocrine remission rate of non-invasive prolactinoma between transsphenoidal surgery treatment and Dopamine agonist treatment.
Detailed Description
Non-invasive prolactinomas were treated by transsphenoidal surgery or Dopamine agonist until now. However，this two type therapies were controversial. The study aim to investigate the endocrine remissi...
Eligibility Criteria
Inclusion
- non-invasive prolactionma
Exclusion
- invasive prolactioma
Key Trial Info
Start Date :
January 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
394 Patients enrolled
Trial Details
Trial ID
NCT03353025
Start Date
January 1 2016
End Date
December 31 2025
Last Update
November 24 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sun Yat-sen 5010 program
Guangzhou, China